Abstract: Image restoration aims to reconstruct a sharp image from its degraded counterpart, which plays an important role in many fields. Recently, Transformer models have achieved promising ...
Abstract: Despite how limiting the symptoms of Epilepsy are in daily life, over a third of epileptic conditions are drug-resistant. These seizures stem from a specific region of the brain: the Seizure ...
Background Seizures are reported to be more prevalent in individuals with multiple sclerosis (MS) compared with the general population. Existing data predominantly originate from population-based ...
A new study has shown that 69% of people who undergo brain surgery for epilepsy do not have seizures with impaired consciousness one year later. This figure decreases to 45% at 10 years, 41% at 20 ...
Please provide your email address to receive an email when new articles are posted on . Seizure freedom was observed by 12 months and continued past 48 months of the open-label extension. Long-term ...
ATLANTA — Epilepsy experts are getting a better picture of the long-term safety and efficacy of azetukalner, a novel and potent Kv7 potassium channel opener, in patients with treatment-resistant focal ...
Monthly reductions in seizure frequency of 90.9% among participants treated for ≥48 months in the OLE, with 38% achieving ≥1 year of seizure freedom New X-TOLE OLE data analysis supports the ability ...
BOSTON and SAN DIEGO, Dec. 05, 2025 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (Rapport or the Company), a clinical-stage biotechnology company dedicated to the discovery and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback